|
시장보고서
상품코드
1973218
담관결석 치료 시장 규모, 점유율, 성장 분석 : 치료법별, 제품 유형별, 적응증별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Choledocholithiasis Treatment Market Size, Share, and Growth Analysis, By Treatment Type (Endoscopic Procedures, Surgical Procedures), By Product Type (Devices, Consumables), By Indication, By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 담관결석 치료 시장 규모는 2024년에 4억 6,550만 달러로 평가되었고, 2025년 4억 8,971만 달러에서 2033년까지 7억 3,462만 달러로 성장할 전망입니다. 예측 기간(2026-2033년) CAGR은 5.2%를 나타낼 것으로 예측됩니다.
세계 담석증 치료 시장은 인구통계학적 변화와 기술 발전을 배경으로 첨단 진단 및 치료법을 통한 담관 결석 관리에 초점을 맞추었습니다. 담관 결석으로 인한 담관염, 췌장염 등의 합병증 위험이 높고, 신속한 개입과 막대한 의료비용이 필요하기 때문에 이 시장은 매우 중요합니다. 기존 수술법에서 내시경적 역행성 담관 췌담관 조영술(ERCP), 레이저 쇄석술과 같은 최소침습적 기술로 전환하면서 치료에 혁명을 가져왔고, 회복 기간 단축과 외래 수술이 가능해졌습니다. 최첨단 내시경 기술의 채택은 지속적으로 성장을 가속하고 있으며, 의료진이 합병증과 입원 기간을 최소화하면서 효과적인 치료를 제공할 수 있도록 돕고 있습니다. AI 기술의 발전은 진단 정확도를 높이고, 워크플로우를 효율화하며, 환자 치료 결과를 개선하고, 궁극적으로 시장 확대와 혁신을 위한 중요한 기회를 창출하고 있습니다.
세계 담석증 치료 시장 성장 촉진요인
세계 총담관 결석증 치료 시장은 이 질환을 관리하는 데 있어 최소 침습적 치료법을 제공하는 내시경 시술에 대한 선호도가 높아짐에 따라 성장하고 있습니다. 의료진은 환자의 합병증 위험 감소 및 회복 기간 단축 등의 이점으로 인해 이러한 기술을 선택하고 있습니다. 임상의의 자신감 향상, 의료기기의 인체공학적 발전, 광범위한 교육 이니셔티브는 다양한 의료 현장에서 내시경 치료에 대한 접근을 용이하게 하여 내시경 치료의 광범위한 도입을 촉진하고 있습니다. 기존 개복 수술에서 내시경 수술로의 전환은 전문 장비 및 소모품에 대한 수요를 자극하고, 임상 가이드라인의 수립을 촉진하며, 시술 기술에 대한 투자를 장려함으로써 관련 치료법 시장을 강화하고 있습니다.
세계 담석증 치료 시장 성장 억제요인
담석증 치료제 세계 시장은 의료진과 환자 모두에게 재정적 불확실성을 야기하는 제한적인 상환 정책의 영향을 크게 받고 있습니다. 시술에 대한 불충분한 보상은 의료진이 첨단 치료기술의 도입을 미루고 더 저렴한 관리 옵션을 선택하는 요인이 될 수 있습니다. 그 결과, 환자들은 본인부담금 증가로 인해 선택적 치료를 기피할 수 있고, 결국 시술 건수가 감소할 수 있습니다. 이러한 상황은 제조업체의 신제품 개발 및 시장 제공 확대에 대한 투자 의욕을 떨어뜨리고, 혁신적인 솔루션의 도입을 지연시켜 전체 시장의 성장을 저해하는 결과를 초래합니다.
세계 총담관 결석증 치료 시장 동향
세계 담석증 치료 시장에서는 환자의 편의성을 높이고 회복 기간을 단축할 수 있는 치료법에 대한 임상적 선호도가 높아지면서 저침습적 시술에 대한 선호가 두드러지게 나타나고 있습니다. 병원과 전문 의료 센터는 내시경 및 경피적 치료법을 우선시하는 조달 전략을 수립하고 있으며, 이로 인해 의료기기 제조업체는 기기의 인체공학적 설계와 호환성에 집중하고 있습니다. 또한, 의료 보험사 및 의뢰 의사는 입원 기간 단축과 관련된 치료 결과를 더 중요하게 여기고 있으며, 제조업체와 의료 서비스 제공업체 간의 치료 경로 최적화를 위한 협력 관계가 형성되고 있습니다. 이러한 진화하는 환경은 첨단 기술의 보급을 촉진하기 위한 혁신적인 교육 프로그램과 다학제적 노력에 의해 더욱 촉진되고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 담관결석 치료 시장 규모 : 치료법별&CAGR(2026-2033)
세계의 담관결석 치료 시장 규모 : 제품 유형별&CAGR(2026-2033)
세계의 담관결석 치료 시장 규모 : 적응증별&CAGR(2026-2033)
세계의 담관결석 치료 시장 규모 : 최종사용자별&CAGR(2026-2033)
세계의 담관결석 치료 시장 규모&CAGR(2026-2033)
경쟁 정보
주요 기업 개요
결론과 제안
LSH 26.03.31Global Choledocholithiasis Treatment Market size was valued at USD 465.5 Million in 2024 and is poised to grow from USD 489.71 Million in 2025 to USD 734.62 Million by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).
The global choledocholithiasis treatment market focuses on managing bile duct stones through advanced diagnostics and therapies, driven by demographic shifts and technological advancements. This market is critical due to the potential complications of obstructing stones, such as cholangitis and pancreatitis, which necessitate timely intervention and significant healthcare costs. The evolution from traditional surgical methods to minimally invasive techniques, including endoscopic retrograde cholangiopancreatography and laser lithotripsy, has revolutionized treatment, reducing recovery times and encouraging outpatient procedures. The adoption of cutting-edge endoscopic technologies continues to spur growth, enabling healthcare providers to deliver effective care while minimizing complications and hospital stays. AI advancements are further enhancing diagnostic accuracy, streamlining workflows, and improving patient outcomes, ultimately creating significant opportunities for market expansion and innovation.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Choledocholithiasis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Choledocholithiasis Treatment Market Segments Analysis
Global choledocholithiasis treatment market is segmented by treatment type, product type, indication, end user and region. Based on treatment type, the market is segmented into Endoscopic Procedures, Surgical Procedures and Medical Management. Based on product type, the market is segmented into Devices and Consumables. Based on indication, the market is segmented into Primary Cause and Complications. Based on end user, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Choledocholithiasis Treatment Market
The Global Choledocholithiasis Treatment market is experiencing growth driven by the increasing preference for endoscopic procedures, which provide a less invasive option for managing this condition. Healthcare providers are choosing these techniques due to their associated benefits of reduced patient morbidity and quicker recovery times. Enhanced clinician confidence, advancements in device ergonomics, and extensive training initiatives have facilitated access to endoscopic treatments across various healthcare settings, promoting wider adoption. This transition from traditional open surgery to endoscopic methods is fueling the demand for specialized instruments and consumables, prompting the development of clinical guidelines and encouraging investments in procedural technologies, thereby bolstering the market for related therapies.
Restraints in the Global Choledocholithiasis Treatment Market
The global market for choledocholithiasis treatment is significantly impacted by restrictive reimbursement policies that create financial unpredictability for both healthcare providers and patients. Inadequate compensation for procedures can lead providers to postpone acquiring advanced therapeutic technologies, opting instead for less costly management options. Consequently, patients may be deterred from pursuing elective treatments due to increased out-of-pocket expenses, ultimately resulting in lower procedure volumes. This situation disincentivizes manufacturers from investing in new product development and expanding market offerings, resulting in a slowdown in the adoption of innovative solutions and hindering overall growth within the market.
Market Trends of the Global Choledocholithiasis Treatment Market
The Global Choledocholithiasis Treatment market is experiencing a significant trend towards minimally invasive procedures, as clinical preferences shift towards options that enhance patient comfort and expedite recovery times. Hospitals and specialty centers are tailoring their procurement strategies to prioritize endoscopic and percutaneous solutions, influencing device manufacturers to focus on ergonomics and compatibility in their instruments. Additionally, healthcare payers and referring clinicians are placing greater importance on outcomes associated with shorter hospital stays, leading to collaborative efforts between manufacturers and healthcare providers for optimized treatment pathways. This evolving landscape is further supported by innovative training programs and cross-disciplinary initiatives aimed at facilitating the widespread adoption of these advanced techniques.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Choledocholithiasis Treatment Market Size by Treatment Type & CAGR (2026-2033)
- Market Overview
- Endoscopic Procedures
- ERCP
- Endoscopic Sphincterotomy
- Surgical Procedures
- Cholecystectomy
- Exploratory Laparotomy
- Medical Management
- Medications
- Supportive Care
Global Choledocholithiasis Treatment Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- Devices
- Biliary Stents
- Lithotripsy Devices
- Consumables
- Surgical Supplies
- Diagnostic Kits
Global Choledocholithiasis Treatment Market Size by Indication & CAGR (2026-2033)
- Market Overview
- Primary Cause
- Gallstones
- Strictures
- Complications
- Cholangitis
- Pancreatitis
Global Choledocholithiasis Treatment Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Specialty Clinics
- Others
Global Choledocholithiasis Treatment Market Size & CAGR (2026-2033)
- North America (Treatment Type, Product Type, Indication, End User)
- US
- Canada
- Europe (Treatment Type, Product Type, Indication, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Treatment Type, Product Type, Indication, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Treatment Type, Product Type, Indication, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Treatment Type, Product Type, Indication, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Boston Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Olympus Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cook Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Conmed Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- B. Braun Melsungen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Intuitive Surgical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hologic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merit Medical Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Amgen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Echosens
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ferring Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Inotek Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DePuy Synthes
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ethicon
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
